Equitix Next Generation Fund is pushing further into Italian biomethane through its platform Andion CH4 Renewables, which has signed a binding agreement to acquire the Cella Dati biomethane plant from IREN and Santini Agricoltura Rinnovabile (SAR). Terms were not disclosed.
The transaction fits a clear pattern in Italy: institutional capital is moving from single-asset deals to platform-led consolidation, aggregating grid-connected plants under operators with access to committed financing.
Why this deal matters
Cella Dati is a relatively small but strategic building block. The plant has 45 GWh of capacity and is expected to expand to 56 GWh, according to the announcement. In isolation, that output is modest versus Andion’s stated ambition to reach more than 1 TWh of production by 2030 across Italy and the Nordics, but it adds an immediately operating, grid-connected asset that can be integrated into a broader operating playbook.
The acquisition also reinforces the notion that Italy’s biomethane market is entering a more industrial phase. Recent moves by Andion, including acquisitions such as Enerland (Bologna) and Cella Dati, point to a “buy and build” approach rather than one-off project exposure.
Platform context: financing enables pace
Andion’s acquisition cadence is underpinned by financing capacity. The platform has secured a EUR 67 million credit facility from Goldman Sachs Alternatives, led by Equitix, to support its project pipeline in Italy and the Nordics. Separately, Andion has also been active in project financing, including a EUR 24 million financing for the Mirandola biomethane plant.
That combination matters for sellers and for competitive dynamics. In fragmented asset bases, buyers with committed debt facilities can move faster, tolerate longer development or upgrade timelines, and standardise technical and commercial operations across a growing portfolio.
What’s known and what isn’t
The Cella Dati announcement does not disclose valuation or deal size, unlike the publicly announced Mirandola financing. Capacity is disclosed, and the expected expansion to 56 GWh suggests an element of post-close capex and optimisation.
Key questions for underwriting and integration include:
- Expansion execution: what capex, timeline and permitting steps are required to move from 45 GWh to 56 GWh, and how exposed is the plan to construction and commissioning risk?
- Feedstock and offtake stability: how resilient are feedstock arrangements and biomethane offtake terms, and what sensitivities exist to operating uptime and input costs?
- Operating model: how Andion will standardise O&M, data systems and compliance across assets as the portfolio scales.
Market signal: consolidation is becoming the default
Cella Dati is another data point that Italian biomethane is consolidating around well-capitalised platforms. The sector benefits from broader energy-transition support, and the competitive set is increasingly shaped by investors that can combine project finance, asset-level optimisation and portfolio operations.
For Equitix and Andion, the strategic logic is straightforward: accumulate high-quality, grid-connected assets, use scale to professionalise operations, and keep optionality for larger future consolidations as more assets come to market.
What to watch next
- Whether Andion discloses a timetable and capex plan for the 45 GWh to 56 GWh expansion
- Additional Italian acquisitions funded by the EUR 67 million facility and any upsizing of that financing
- Evidence of operating standardisation across Enerland, Cella Dati and other assets (systems, uptime, compliance)
- Further M&A activity by other institutional platforms as competition for operating plants increases